Tricyclic compounds as anticancer agents
US9540358B2 · kind B2 · utility
6Cited by
2References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 16, 2012 |
| Grant date | Jan 10, 2017 |
| Priority date | — |
| Expiry date | Dec 30, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC09B21/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Tricyclic chemical modulators of FOXO transcription factor proteins are disclosed. The compounds are useful to treat cancer, age-onset proteotoxicity, stress-induced depression, inflammation, and acne. The compounds are of the following phenothiazine, dibenzoazepine and annulene and similar genera:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.